• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ALGORITHM FOR INVESTIGATION AND MANAGEMENT OF POSSIBLE CASES OF SEVERE ACUTE RESPIRATORY ILLNESS ASSOCIATED WITH A NOVEL CORONAVIRUS (HPA UK, December

Giuseppe

Emeritus
[Source: Health Protection Agency, United Kingdom, full PDF document: (LINK). Edited.]

HPS CASE MANAGEMENT ALGORITHM Version No. case_v9 03/12/2012 / For all email contact with HPS Colindale, please use respiratory.lead@hpa.org.uk

ALGORITHM FOR INVESTIGATION AND MANAGEMENT OF POSSIBLE CASES OF SEVERE ACUTE RESPIRATORY ILLNESS ASSOCIATED WITH A NOVEL CORONAVIRUS



POSSIBLE CASE

PATIENT UNDER INVESTIGATION
  • Any person with severe acute respiratory infection;
  • Symptoms of fever (≥ 38⁰C) or history of fever and cough
    • AND
      • With evidence of pulmonary parenchymal disease (eg. pneumonia or Acute Respiratory Distress Syndrome (ARDS)) based on clinical or radiological evidence)
    • AND
  • Not explained by any other infection or aetiology (1)
    • AND EITHER
      • History of travel to or residence in an area(2) where infection with novel coronavirus 2012 has recently been reported or where transmission could have occurred in the ten days before onset of illness
        • OR
      • Healthcare worker based in ICU caring for patients with severe acute respiratory infection
        • OR
      • Close contact (i.e. prolonged face-to-face contact) during the ten days before onset of illness with a confirmed case of novel coronavirus infection while the case was ill
OR
  • CLUSTER(3)
    • Two or more cases of severe acute respiratory infection requiring ICU admission, regardless of history of travel
      • AND
    • Not explained by any other infection or aetiology (1)
(1) including all clinically indicated tests for community or hospital acquired pneumonia

(2) as of 03/12/2012:, Bahrain, Iraq, Israel, Jordan, Kingdom of Saudi Arabia, Kuwait, Lebanon, Oman, Qatar, Syria, UAE and Yemen ? see map http://www.un.org/Depts/Cartographic/map/profile/mideastr.pdf

(3) Cluster is defined as two or more cases within a specific closed setting (eg. classroom, workplace, household, hospital, other residential institution), developing symptoms within the same two week period



MEETS POSSIBLE CASE DEFINITION
REGIONAL LAB TEST NEGATIVE FOR NOVEL CORONAVIRUS -----> DISCARD



REGIONAL LAB TEST POSITIVE FOR NOVEL CORONAVIRUS
  • Ensure HPU is notified
  • HPU informs HPS Colindale by email
  • HPU collates list of contacts* using contact line list ? email to HPS Colindale
  • ADDITIONALLY FOLLOW ?CLOSE CONTACT OF A CASE POSITIVE FOR NOVEL CORONAVIRUS FOLLOW UP ALGORITHM?
BASELINE

FOLLOW UP
______________________________
! Baseline clotted blood sample should be taken asap and ideally no later than 7 days after symptom onset. Followup sample should be taken at least 14 days after the baseline sample, or 28 days after illness onset if a sample couldn?t be taken when case was symptomatic.

(*) Contact definitions (from date of illness onset in index case and throughout their symptomatic period):
  • Health and social care workers: worker who provided direct clinical or personal care or examination of a symptomatic case positive for novel coronavirus or within close vicinity of an aerosol generating procedure AND who were not wearing full personal protective equipment (PPE***) at the time.
  • Household or close contact: any person who has had prolonged face-to-face contact (>15 minutes) with a symptomatic case positive for novel coronavirus in a household or other closed setting.
(**) Full PPE is defined as correctly fitted high filtration respirator (FFP3), gown, gloves and eye protection.



-
--------
 

Attachments

Back
Top Bottom